Carna Biosciences, Inc. (4572.T)
JPY 280.0
(-1.41%)
JPY 280.0
(-1.41%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.7 Billion JPY | 12.1% |
| 2022 | -3.07 Billion JPY | 6.08% |
| 2021 | -3.27 Billion JPY | 15.28% |
| 2020 | -3.86 Billion JPY | 7.57% |
| 2019 | -4.18 Billion JPY | -526.05% |
| 2018 | -668.68 Million JPY | 45.73% |
| 2017 | -1.23 Billion JPY | 15.81% |
| 2016 | -1.46 Billion JPY | -3.69% |
| 2015 | -1.41 Billion JPY | -202.95% |
| 2014 | -465.86 Million JPY | 49.75% |
| 2013 | -927.03 Million JPY | -77.98% |
| 2012 | -520.85 Million JPY | -4.53% |
| 2011 | -498.27 Million JPY | 34.12% |
| 2010 | -756.31 Million JPY | 37.63% |
| 2009 | -1.21 Billion JPY | -45.84% |
| 2008 | -831.54 Million JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -2.93 Billion JPY | 3.39% |
| 2024 Q1 | -3.04 Billion JPY | -12.37% |
| 2023 Q4 | -2.7 Billion JPY | 15.76% |
| 2023 Q2 | -3.45 Billion JPY | 9.6% |
| 2023 FY | -2.7 Billion JPY | 12.1% |
| 2023 Q3 | -3.21 Billion JPY | 7.11% |
| 2023 Q1 | -3.82 Billion JPY | -24.26% |
| 2022 Q3 | -3.39 Billion JPY | 20.64% |
| 2022 Q2 | -4.27 Billion JPY | 3.02% |
| 2022 Q1 | -4.41 Billion JPY | -34.59% |
| 2022 FY | -3.07 Billion JPY | 6.08% |
| 2022 Q4 | -3.07 Billion JPY | 9.33% |
| 2021 Q3 | -3.51 Billion JPY | -21.84% |
| 2021 Q2 | -2.88 Billion JPY | 14.34% |
| 2021 Q1 | -3.36 Billion JPY | 12.94% |
| 2021 Q4 | -3.27 Billion JPY | 6.76% |
| 2021 FY | -3.27 Billion JPY | 15.28% |
| 2020 Q2 | -4.34 Billion JPY | 5.25% |
| 2020 Q1 | -4.58 Billion JPY | -9.45% |
| 2020 FY | -3.86 Billion JPY | 7.57% |
| 2020 Q4 | -3.86 Billion JPY | 9.0% |
| 2020 Q3 | -4.25 Billion JPY | 2.06% |
| 2019 FY | -4.18 Billion JPY | -526.05% |
| 2019 Q1 | -569.44 Million JPY | 14.84% |
| 2019 Q2 | -769.49 Million JPY | -35.13% |
| 2019 Q3 | -3.8 Billion JPY | -394.85% |
| 2019 Q4 | -4.18 Billion JPY | -9.94% |
| 2018 Q3 | -396.17 Million JPY | 42.4% |
| 2018 Q4 | -668.68 Million JPY | -68.79% |
| 2018 Q2 | -687.81 Million JPY | 27.38% |
| 2018 FY | -668.68 Million JPY | 45.73% |
| 2018 Q1 | -947.17 Million JPY | 23.13% |
| 2017 Q3 | -1.38 Billion JPY | -8.04% |
| 2017 FY | -1.23 Billion JPY | 15.81% |
| 2017 Q4 | -1.23 Billion JPY | 10.89% |
| 2017 Q2 | -1.27 Billion JPY | 7.74% |
| 2017 Q1 | -1.38 Billion JPY | 5.22% |
| 2016 Q1 | -1.61 Billion JPY | -14.09% |
| 2016 FY | -1.46 Billion JPY | -3.69% |
| 2016 Q4 | -1.46 Billion JPY | 7.39% |
| 2016 Q3 | -1.58 Billion JPY | 9.73% |
| 2016 Q2 | -1.75 Billion JPY | -8.72% |
| 2015 Q2 | -1 Billion JPY | -189.5% |
| 2015 Q1 | -347.22 Million JPY | 25.47% |
| 2015 FY | -1.41 Billion JPY | -202.95% |
| 2015 Q4 | -1.41 Billion JPY | 11.75% |
| 2015 Q3 | -1.59 Billion JPY | -59.09% |
| 2014 FY | -465.86 Million JPY | 49.75% |
| 2014 Q4 | -465.86 Million JPY | 25.19% |
| 2014 Q3 | -622.72 Million JPY | 12.27% |
| 2014 Q2 | -709.82 Million JPY | 10.32% |
| 2014 Q1 | -791.48 Million JPY | 14.62% |
| 2013 FY | -927.03 Million JPY | -77.98% |
| 2013 Q1 | -470.45 Million JPY | 9.68% |
| 2013 Q2 | -559 Million JPY | -18.82% |
| 2013 Q3 | -999.11 Million JPY | -78.73% |
| 2013 Q4 | -927.03 Million JPY | 7.21% |
| 2012 FY | -520.85 Million JPY | -4.53% |
| 2012 Q2 | -455.49 Million JPY | -22.51% |
| 2012 Q3 | -331.04 Million JPY | 27.32% |
| 2012 Q4 | -520.85 Million JPY | -57.34% |
| 2012 Q1 | -371.79 Million JPY | 25.38% |
| 2011 FY | -498.27 Million JPY | 34.12% |
| 2011 Q4 | -498.27 Million JPY | 16.19% |
| 2011 Q1 | -755.62 Million JPY | 0.09% |
| 2011 Q3 | -594.49 Million JPY | 15.13% |
| 2011 Q2 | -700.45 Million JPY | 7.3% |
| 2010 Q1 | -977.44 Million JPY | 19.4% |
| 2010 Q2 | -917.45 Million JPY | 6.14% |
| 2010 Q4 | -756.31 Million JPY | 5.75% |
| 2010 FY | -756.31 Million JPY | 37.63% |
| 2010 Q3 | -802.49 Million JPY | 12.53% |
| 2009 Q4 | -1.21 Billion JPY | -43.89% |
| 2009 Q3 | -842.78 Million JPY | -19.33% |
| 2009 Q2 | -706.29 Million JPY | 1.42% |
| 2009 Q1 | -716.48 Million JPY | 0.0% |
| 2009 FY | -1.21 Billion JPY | -45.84% |
| 2008 FY | -831.54 Million JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 742.75 Million JPY | 464.335% |
| PRISM BioLab Co.,LTD | -1.13 Billion JPY | -138.648% |
| GNI Group Ltd. | -17.93 Billion JPY | 84.91% |
| Linical Co., Ltd. | -4.46 Billion JPY | 39.369% |
| Trans Genic Inc. | -221.16 Million JPY | -1123.558% |
| MEDINET Co., Ltd. | -4.39 Billion JPY | 38.413% |
| Soiken Holdings Inc. | -4.79 Billion JPY | 43.505% |
| Cytori Cell Research Institute, Inc. | 1.43 Billion JPY | 288.773% |
| AnGes, Inc. | -3.79 Billion JPY | 28.744% |
| OncoTherapy Science, Inc. | -420.8 Million JPY | -543.081% |
| Nxera Pharma Co., Ltd. | 24.9 Billion JPY | 110.865% |
| Immuno-Biological Laboratories Co., Ltd. | -498.15 Million JPY | -443.232% |
| NanoCarrier Co., Ltd. | -466.34 Million JPY | -480.282% |
| CanBas Co., Ltd. | -1.88 Billion JPY | -43.318% |
| D. Western Therapeutics Institute, Inc. | -982.14 Million JPY | -175.533% |
| RaQualia Pharma Inc. | -3.39 Billion JPY | 20.338% |
| Chiome Bioscience Inc. | -1.03 Billion JPY | -161.575% |
| Kidswell Bio Corporation | 343.58 Million JPY | 887.607% |
| PeptiDream Inc. | 3.29 Billion JPY | 182.203% |
| Oncolys BioPharma Inc. | -972.59 Million JPY | -178.239% |
| Ribomic Inc. | -2.09 Billion JPY | -28.879% |
| SanBio Company Limited | -3.78 Billion JPY | 28.593% |
| Healios K.K. | -2.19 Billion JPY | -23.568% |
| BrightPath Biotherapeutics Co., Ltd. | -944.85 Million JPY | -186.405% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -2.62 Billion JPY | -3.124% |
| Delta-Fly Pharma, Inc. | -1.41 Billion JPY | -90.968% |
| StemRIM | -8.41 Billion JPY | 67.822% |
| CellSource Co., Ltd. | -4.68 Billion JPY | 42.22% |
| FunPep Company Limited | -1.79 Billion JPY | -50.896% |
| Kringle Pharma, Inc. | -2.13 Billion JPY | -26.662% |
| Stella Pharma Corporation | -1.11 Billion JPY | -141.747% |
| TMS Co., Ltd. | -3.44 Billion JPY | 21.485% |
| Noile-Immune Biotech Inc. | -5.55 Billion JPY | 51.291% |
| Cuorips Inc. | -5.56 Billion JPY | 51.337% |
| K Pharma,Inc. | -3.26 Billion JPY | 17.153% |
| Takara Bio Inc. | -32.2 Billion JPY | 91.597% |
| ReproCELL Incorporated | -2.93 Billion JPY | 7.925% |
| PhoenixBio Co., Ltd. | -660.96 Million JPY | -309.424% |
| StemCell Institute Inc. | -2.83 Billion JPY | 4.605% |
| Japan Tissue Engineering Co., Ltd. | -2.06 Billion JPY | -30.962% |
| CellSeed Inc. | -2.01 Billion JPY | -34.497% |